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Abstract
Purpose This review aims to compare the magnitude of the effects of chronic consumption of fruits; specifically berries, 
citrus and cherries on cardiovascular disease (CVD) risk factors.
Methods PubMed, Web of Science, Scopus, and psycARTICLES were searched from inception until January 2020. Forty-
five chronic (≥ 1 week) randomised controlled trials assessing CVD risk factors including endothelial (dys)function, blood 
pressure (BP), blood lipids and inflammatory biomarkers were included.
Results Investigated interventions reported improvements in endothelial function (n = 8), inflammatory biomarkers and lipid 
status (n = 14), and BP (n = 10). Berries including juice of barberry, cranberry, grape, pomegranate, powder of blueberry, 
grape, raspberry and freeze-dried strawberry significantly reduced SBP by 3.68 mmHg (95% CI − 6.79 to − 0.58; P = 0.02) 
and DBP by 1.52 mmHg (95% CI − 2.87 to − 0.18, P = 0.04). In subgroup analysis, these associations were limited to 
cranberry juice (SBP by 1.52 mmHg [95% CI − 2.97 to − 0.07; P = 0.05], DBP by 1.78 mmHg [95% CI − 3.43 to − 0.12, 
P = 0.04] and cherry juice (SBP by 3.11 mmHg [95% CI − 4.06 to − 2.15; P = 0.02]). Berries also significantly elevated 
sVCAM-1 levels by 14.57 ng/mL (85% CI 4.22 to 24.93; P = 0.02).
Conclusion These findings suggest that supplementing cranberry or cherry juice might contribute to an improvement in blood 
pressure. No other significant improvements were observed for other specified fruits. More research is warranted comparing 
different classes of fruit and exploring the importance of fruit processing on their cardiovascular-protective effects.
Keywords Fruit · Intervention · Endothelial function · CVD risk factors · Systematic review · Meta-analysis
Introduction
Current World Health Organization (WHO) recommenda-
tions for fruit intake combined with vegetable intake are a 
minimum 400 g/day [1]. A recent meta-analysis indicated 
that the intake of 800 g/day of fruit was associated with a 
27% reductions in relative risk of CVD [2]. It is well recog-
nised that cardiovascular health can be affected by several 
dietary factors [3]. Epidemiological evidence has established 
strong inverse associations between flavonoid-rich fruit (e.g. 
strawberries, grapefruit) and coronary heart disease (CHD) 
mortality in CVD-free postmenopausal women after mul-
tivariate adjustment [4]. Endothelial function is a primary 
indicator of cardiovascular health, a damaged endothelium 
will cause disruption of vascular hemostasis and further 
lead to endothelial dysfunction, which is the manifestation 
underlying atherosclerosis, hypertension, and other CVDs 
[5, 6]. Intervention studies also provide evidence supporting 
the consumption of a range of fruit and fruit juice to reduce 
cardiovascular dysfunction risk factors. For example, con-
sumption of fruit containing relatively high levels of antho-
cyanins and procyanidins, such as berries, has been shown to 
improve CVD risk factors, namely endothelial dysfunction, 
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dyslipidaemia, platelet aggregation, and hypertension [7, 8], 
whereas flavanone-rich citrus, such as orange, were effective 
in improving hypercholesterolaemia [7]. The consumption 
of cherries was also suggested by interventions to promote 
cardiovascular health by preventing or decreasing lipid lev-
els and inflammation [9]. One systematic review and epide-
miological evidence have also revealed that the consump-
tion of fruit juice including citrus, berries and cherry juice 
may benefit vascular health by affecting risk markers such 
as blood pressure and lipid profiles [10, 11].
Fruit juice and powder may be effective methods to 
increase overall fruit consumption, which may explain the 
emerging intervention studies investigating health benefits 
with fruit powder and juice supplementations. With regard 
to nutritional value, freeze-dried fruit powder that is devoid 
of water retains concentrated bio-accessible antioxidants, 
fibre and other components [10]. Research has suggested 
that the juicing process can lead to a lower content of fibre 
and certain bioactives such as polyphenols, vitamins, and 
minerals [12, 13], while other research suggests that pro-
cessing can increase the bioavailability of carotenoids, such 
as lycopene [14]. A recent single-dose bioavailability study 
showed only minor differences between whole blueberry 
fruit and blueberry juice [15]; indeed a systematic review 
demonstrated that the intake of fruit and vegetable juice 
offered similar cardiovascular health benefits to the intake 
of whole fruit and vegetables [16].
Other systematic reviews have assessed the effect of fruit 
and vegetable intake on endothelial function or the effect of 
specific fruit juice intake on CVD risk factors [17, 18]. How-
ever, to the best of our knowledge, the effects of the fruit-
delivery method (type and processed form) in relation to 
CVD risk factors including endothelial (dys)function, lipid 
profile (i.e. total cholesterol) and inflammatory biomark-
ers (i.e. C-reactive protein/CRP) has not been appraised. A 
review of this type is important to clarify the evidence base 
for the type and form of fruit that is most cardiovascular-
protective. Therefore, the aim of this study was to systemati-
cally review and meta-analyse available human intervention 
studies to evaluate the potential effect of consumption of 
whole, freeze-dried, powdered, and juiced forms of fruit, 
and specifically berry, citrus and cherry fruit, on CVD risk 
factors in randomised controlled trials (RCTs) in line with 
the PICOS (population, intervention, comparator, outcome, 
study design) framework (Supplemental Table 1).
Methods
Study eligibility
We searched for studies assessing the effect of specific fruit 
supplementations on CVD risk factors including terms of 
“fruit”, “CVD risk factors”, “endothelial function”, “BP”, 
“lipid”, “inflammatory biomarker”. The following specific 
inclusion criteria were applied: (1) study design: RCTs; (2) 
subjects: adult subjects ≥ 18 years of age; (3) interventions: 
intervention RCTs providing or promoting berry, or cherry 
or citrus fruit or their juice or freeze-dried, or powdered fruit 
consumption; (4) intervention length: at least 1 week; (5) 
control: control groups without components of citrus fruit, 
cherry, or berries, likely placebo group; (6) outcomes: the 
primary outcomes were the whole body measurements: sys-
tolic and diastolic blood pressure (SBP and DBP) and the 
endothelial (dys)function assessed by flow-mediated dila-
tion (FMD) and pulse wave velocity (PWV); the secondary 
outcomes were the blood biomarkers including circulating 
fatty acids triglycerides (TAGs) and total cholesterol (TC), 
low-density lipoprotein cholesterol (LDL-C) and high-
density lipoprotein (HDL-C); inflammatory biomarkers 
such as high-sensitivity C-reactive protein (hsCRP), nitric 
oxide (NO), intercellular adhesion molecules (ICAMs) and 
vascular adhesion molecules (VCAMs) were also explored 
(described below); (7) only English-language and peer-
reviewed articles were included. No restriction of publica-
tion year was applied.
Data sources
The present systematic review and meta-analysis was 
conducted in accordance with Cochrane [19] and Centre 
for Reviews and Dissemination guidelines [20] and was 
reported according to PRISMA guidelines [21] (Supplemen-
tal Table 2). The protocol has been registered with PROS-
PERO, the International Prospective Register of Systematic 
Reviews (Registration number CRD42018091896). Such 
protocol includes the investigation of the impact of these 
fruits on cognitive function, however this analysis will be 
reported elsewhere. Two researchers (YW, JLG) assessed 
articles independently for inclusion eligibility. The searches 
using PubMed, Web of Science, Scopus and psycARTI-
CLES were conducted from inception until January 2020. 
No restriction of publication year was applied and the search 
result covered studies published between 1960 and 2020.
The search of the investigated themes in this review was 
undertaken using terms as following: (1) fruit; (2) citrus; 
(3) orange; (4) berry; (5) berries; (6) grape; (7) blueberry; 
(8) blueberries; (9) blackberry; (10) blackberries; (11) 
raspberry; (12) raspberries; (13) cranberry; (14) cranber-
ries; (15) cherry; (16) cherries; (17) “endothelial function”; 
(18) “vascular function”; (19) “vascular risk factors”; (20) 
hypertension; (21) “blood pressure”; (22) BP; (23) “pulse 
wave velocity”; (24) PWV; (25) “flow-mediated dilation”; 
(26) FMD; (27) lipid; (28) cholesterol; (29) LDL; (30) HDL; 
(31) triglyceride; (32) biomarkers; (33) inflammatory; (34) 
“Nitric Oxide”; (35) NO; (36) ICAM; (37) VCAM; (38) 
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hsCRP; (39) trial; (40) intervention. Search strategy was 
supplied (Supplemental Table 3).
Study selection
YW and JLG selected articles independently for eligibil-
ity. Articles were moved to the next screening phase or dis-
carded when full disagreement was reached. JKL served as 
an arbitrator if any disagreements that were not resolved. 
No disagreements occurred during the selection phase. All 
records were exported to EndNote X8 reference manage-
ment software. The selection of eligible studies was based 
on two steps. Firstly, the title and abstract of each study 
were screened for relevance; full texts were then reviewed 
for those without certainty for inclusion. Reference lists of 
included papers and relevant systematic reviews were also 
screened by hand-searching for additional articles.
Data abstraction
Data were extracted by YW and JLG independent of each 
other, their selections for accuracy were reviewed in meet-
ing. Corresponding authors were contacted via e-mail to 
request information if there were missing data or for clarifi-
cation. Data from endpoints and the baseline were obtained. 
A pre-defined data extraction form in Microsoft Excel 2016 
was used to input studies data, which includes information 
on (1) author and published year; (2) study design; (3) popu-
lation characteristics (ethnicity, mean age, sex, mean body 
mass index (BMI), health status and sample size at baseline); 
(4) treatment details (intervention type, length, dosage and 
frequency); (5) control group settings; (6) retention rate; (7) 
measured outcomes for both experimental group and pla-
cebo group at baseline and the longest post-intervention time 
point to avoid the bias of selectively choosing data.
Risk of bias assessments
Study quality for RCTs was assessed by Jadad Score (0–5), 
which takes into account whether a trial was randomised and 
blinded with appropriate procedure, and whether dropouts 
were well recorded; a score ≥ 3 indicates a high-quality trial 
[22].
Publication bias was assessed by Funnel plot and Egger’s 
test, ‘trim and fill’ method was implemented to identify and 
correct for funnel plot asymmetry arising from publication 
bias [23] (Supplemental Fig. 1).
Data synthesis
R studio version 3.5.2 [24] and the package “meta” 
[25] were used to pool and meta-analyse data from col-
lected studies. Subgroup analysis with at least 10 studies 
supplementing berries was implemented to estimate sepa-
rate effects of different types of berries and the heteroge-
neity for each berry intervention subgroup. There were 3 
studies supplementing grapefruit juice and cherry juice 
as concentrate instead of 100% juice, which could cause 
variations to the juice quality and bioavailability [26–28]. 
For example, anthocyanins are better preserved in purees 
(57%) than in clarified juice (31%) when comparing dif-
ferent forms of processed blackberries [29]. Sensitivity 
analysis of juice quality was carried out to investigate the 
effect of juice on the meta-analysis results.
All pooled results were presented as weighted mean 
difference with 2-sided p values. 95% confidence intervals 
(CIs) and prediction intervals were both presented in the 
results. The FMD value was expressed in percentage unit 
and the PWV value was expressed in m/s; the conversion 
of cm/s to m/s for PWV value was applied when neces-
sary for pooled mean differences in meta-analysis. For 
blood lipids, the conversion factor 1 mmol/L = 38.67 mg/
dL was used for total, HDL, and LDL cholesterol level 
and 1 mmol/L = 88.57 mg/dL for triglycerides level [30] 
where applicable.
The Hartung–Knapp–Sidik–Jonkman method for ran-
dom-effects meta-analysis [31] was applied. Heterogeneity 
was estimated by Cochrane Q statistics and the consistency 
of study results was assessed by I2 statistics as an exten-
sion of Cochrane Q statistics and an I2 > 50% is consid-
ered for a high heterogeneity level [32]. The effect sizes 
based on the weighted mean difference (WMD) between 
treatment groups were used when measurement units of 
assessed outcomes were comparable across studies. The 
standardised mean difference (SMD) was used when stud-
ies have used different measurement units and the conver-
sion had failed.
Results
Literature search
In accordance with PRISMA guidelines [21], Fig.  1 
describes the selection process of included studies. The ini-
tial search produced 13,861 articles from the four databases, 
this record was reduced to 8613 articles after duplicates were 
removed. After screening of the titles and abstracts for eli-
gibility, 51 articles were included and 10 additional articles 
were added from manual search through reference lists of 
initially identified articles. The final selection identified 61 
trials assessing CVD risk factors, where 16 articles were fur-
ther excluded after checking full-text eligibility (Supplemen-
tal Table 4). Finally 45 trials were included in this review, 38 
trials from these were included in the meta-analysis.
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Study characteristics
Forty-five studies were included in this systematic review, of 
which 18 were crossover randomised controlled trials (RCT) 
[27, 33–49], and 27 were parallel RCTs [26, 28, 50–74] (see 
Table 3). The sample size of both experimental and control 
group in the interventions ranged from 5 to 63. The total 
sample size for the intervention group was 1130; the total 
sample size for the control group was 1109. Participants’ 
characteristics at baseline also vary across studies; most tri-
als recruited healthy subjects (n = 13), while there were 7 
studies with participants manifesting increased CVD risks 
(deteriorated lipid profiles and hypertension) and 3 with 
diagnosed CVD/CHD; 18 with metabolic syndrome (inclu-
sive of overweight); 1 with mild-to-moderate dementia, 1 
with chronic obstructive pulmonary disease, 1 with type 2 
diabetes and 1 with end-stage renal disease (Table 3).
Results from 32 studies (71% of the interventions) that 
supplemented fruit juice are shown in Table 1, while studies 
supplementing whole fruit and fruit in other freeze-dried 
forms (13 studies), are presented in Table 2. Study effects are 
represented with greyscales in corresponding with reported 
positive, negative effects and no effect compared to either 
control or baseline data. Treatments were all delivered in 
Fig. 1  Flow diagram of study selection for the review according to PRISMA guidelines
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Table 1  Qualitative summarisation for fruit juice interventions
-ylgirTVWPPBDPBSDMFydutSnoitatnemelppuS
cerides 
Total 
cholesterol 
LDL-C HDL-C ICAM/      
sICAM 
VCAM/ 
sVCAM 
hsCRP NO/       
xNO 
cranberry juice Novotny et al., 2015 (US) - ↓ ↓ - - - - - ↓ 
Dohadwala, et al., 2011 (US) - - - ↓ - - - ↑ - - -   
Chew, B., et al. (2019) US - - - ↑  ↓ ↑ 
Flammer, et al., 2013 (US) - - - - - - - - - 
Ruel, et al., 2013 (Canada) - -  -  - -  - 
Basu, et al., 2011 (US) - -  - - - -  
Duthie, et al., 2006 (Scotland) - - - -         
grape juice Siasos, et al., 2014 (Greece) ↑ - - ↓ - - - 
Leal, et al., 2019 (Brazil) ↓ ↓  
Dohadwala, et al., 2010 (US) - -  - - - -  
Lamport, et al., 2016 (UK) - - 
Hollis, et al.,  2010 (US) - - - -         
pomegranate juice Boldaji, et al., 2020 (Iran) ↓ ↓ ↓ - - ↑ 
Lynn, et al., 2012 (UK)  ↓ ↓ -  
Summer, et al., 2005 (US)  - -  - - - -  
Gonzalez-Ortiz, et al., 2011 (US)     - - - -  
Cerda, et al., 2006 (Spain)     - - - -  
cherry juice Desai, T., et al. (2018) UK - -   - - - ↓         
Chai, S. C., et al. (2019).US       -  ↓ - 
Kent, et al., 2017 (Australia)  ↓ -  -   
Lynn, et al., 2014 (UK) - - - - - - 
Martin, 2018 (US) -   
orange juice Buscemi, et al., 2012 (Italy ↑  ↓ - 
Hollands, et al., 2018 (UK) - - - - - - -  - - 
Morand, et al., 2011 (French) - - - - - - - - - - 
Constans, et al., 2015 (France) - - - - - - 
blueberry juice Basu, et al., 2010  (US) ↓ ↓ - - ↓ - - - - 
grapefruit juice Habauzit, et al., 2015 (France) - - - ↓ - - - - 
blackcurrant juice Khan, et al., 2014 (UK) ↑ - - - 
barberry juice Lazavi, et al., 2018 (Iran)   ↓ ↓ ↓ ↓ - - 
strawberry juice Basu, et al., 2010  (US) (2)  - - - ↓ ↓ - ↓ 
acai berry juice Kim, 2018 (US) - - - 
Significant negative effect compared to control;
Significant improvement compared to control; Significant improvement compared to baseline;
Non-significant effects
Table 2  Qualitative summarisation for whole fruit or freeze-dried or powdered fruit interventions
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arms of experimental and control groups. The mean chronic 
treatment duration was 57 days with a standard deviation 
(SD) of 43 days (ranged from 7 days to 180 days).
Among the fruit juice category, most studies evaluated 
the effect of cranberry juice, grape juice, pomegranate juice, 
cherry juice, orange juice (n = 7, 5, 5, 5, 4, respectively). The 
mean dosage applied for these types of juices was 480 mL, 
353 mL, 238 mL, 173.6 mL and 425 mL, respectively. The 
remaining interventions included blueberry juice (n = 1), 
grapefruit juice (n = 1), barberry juice (n = 1), blackcurrant 
juice (n = 1), strawberry juice (n = 1) and acai berry juice 
(n = 1) (see Table 1). In Table 2, four trials supplemented 
freeze-dried blueberry powder. Portion conversion of pow-
der to whole fruit was provided in each study; typically the 
mean dosage of blueberry powder supplementations was 
32.75 g (equivalent to approximately 1.5 cups of fresh blue-
berries). Three trials supplemented freeze-dried grape pow-
der. The mean dosage of grape powder supplemented was 
55.33 g, which is equivalent to approximately 2.5 cups of 
fresh grapes. The remaining 5 studies supplemented other 
berries (powdered raspberry, powdered blackcurrant, freeze-
dried strawberry) and citrus fruit (1.5 portion of grapefruit 
following a low bioactive diet).
Study quality
The average retention rate for all included trials was 92.64%, 
of which 30 out of 45 RCTs obtained no less than 3 points 
of total Jadad score (see Table 3). Trials generally provided 
adequate description of methods and procedures, although 
only 40% of RCTs implemented true randomisation with an 
adequate description of methods (i.e. computerised statis-
tical randomisation) and 33.33% of RCTs reported imple-
menting blinding processes, where the placebo were col-
our and taste matched to mask treatments, and the received 
treatment was not revealed until the statistical analysis was 
completed for double blinding. However, there was no report 
assessing participants’ blinding for instance by guessing the 
treatment they received (Supplemental Table 5).
Meta‑analysis of CVD risk factors
Thirty-eight trials were included in the meta-analysis. The 
meta-analysis of 38 studies assessing FMD, PWV, SBP, 
DBP, levels of TAG, TC, HDL-C and LDL-C and levels of 
vascular inflammatory biomarkers ICAMs, VCAMs, hsCRP 
and NO are displayed in forest plots (Figs. 2, 3, 4, 5 and 
Supplemental Figs. 2–17). The interventions used in these 
studies supplemented: blueberry powder, grape juice and 
grape powder, cranberry juice, orange juice, whole grape-
fruit, pomegranate juice, raspberry powder, freeze-dried 
strawberry, acai berry juice and barberry juice. Among 
investigated outcomes, no significant improvements were 
shown to either FMD or PWV in the treatment group rel-
ative to the control group (Fig. 2). The I2 test suggested 
no heterogeneity for interventions assessing the effect on 
FMD (I2 = 0%, P = 0.39) and non-significant moderate het-
erogeneities for interventions assessing the effect on PWV 
(I2 = 58%, P = 0.07).
Our principal findings from a meta-analysis of interven-
tions supplementing with berries (including 531 and 502 
treatment participants) including barberry juice, blueberry 
powder, cranberry juice, freeze-dried strawberry, grape 
juice, grape powder, pomegranate juice and raspberry pow-
der suggested significantly reduced SBP by 3.68 mmHg 
[95% CI − 6.79 to − 0.58; P = 0.02] (Fig. 3) and DBP by 
1.78 mmHg [95% CI − 3.43 to − 0.12; P = 0.04] (Fig. 4), 
respectively. Subgroup analysis showed that specific inter-
ventions using cranberry juice, with mean dosage of 432 mL 
and length of 8 weeks, included 149 treatment participants 
and significantly decreased SBP and DBP by 1.52 mmHg 
(95% CI − 2.97 to − 0.07; P = 0.05) (Fig. 3) and 1.52 mmHg 
(95% CI − 2.87 to − 0.18, P = 0.04) (Fig. 4), respectively. 
Two cherry juice interventions including 36 treatment par-
ticipants with dosage of 30 mL for 20 days and 330 mL 
for 6 weeks separately also led to a significant reduction in 
SBP by 3.11 mmHg (95% CI − 4.06 to − 2.15; P = 0.02) 
(Fig. 5). Berry group including blueberry juice, cranberry 
juice, grape powder, pomegranate juice and raspberry pow-
der was also shown to significantly increase sVCAM-1 level 
by 14.57 ng/mL (95% CI 4.22 to 24.93, P = 0.02) in the treat-
ment group relative to the control (Supplemental Fig. 12). 
The sensitivity analysis suggested no effect of grapefruit 
concentrate juice on the result of SBP and no effect of cherry 
concentrate juice on the results of SBP, DBP (Supplemental 
Table 6). The I2 test suggested significant substantial hetero-
geneities for berry group investigating the effects on SBP 
(I2 = 78%, P < 0.01) (Fig. 3) and DBP (I2 = 78%, P < 0.01) 
(Fig. 4). Funnel plots and the Egger’s test for the berry group 
showed an overall symmetric distribution of the interven-
tions around the standard error for the investigated outcomes 
of SBP; asymmetric distributions were shown for the berry 
group investigating the effect on DBP, trim and fill method 
was further implemented to adjust for the publication bias 
(Supplemental Fig. 1).
There were no significant effects of other included 
intervention groups on other vascular and inflammatory 
markers: TAG (Supplemental Figs. 2, 3), TC (Supplemen-
tal Figs. 4, 5), LDL-C (Supplemental Figs. 6, 7), HDL-C 
(Supplemental Figs. 8, 9), ICAMs (Supplemental Figs. 10, 
11), VCAMs (Supplemental Figs. 12, 13), NO (Supplemen-
tal Figs. 14, 15), or hsCRP (Supplemental Figs. 16, 17). 
The I2 test suggested significant substantial and moderate 
heterogeneities for berry group (I2 = 71%, P < 0.01) and 
cherry juice (I2 = 55%, P = 0.14) investigating the effects 
on TC, respectively (Supplemental Figs. 4, 5). There are 
European Journal of Nutrition 
1 3
significant moderate heterogeneity for berry group inves-
tigating the effects on HDL-C (I2 = 56%, P < 0.01) (Sup-
plemental Fig. 8); non-significant moderate heterogeneities 
were shown for berry group investigating the effects on TAG 
(I2 = 36%, P = 0.08) (Supplemental Fig. 2), LDL (I2 = 37%, 
P = 0.08) (Supplemental Fig. 6). Funnel plots and the Egg-
er’s test for the berry group showed an overall symmetric 
distribution of the interventions around the standard error 
for the investigated outcomes of TAG, TC, LDL-C (Egger’s 
tests P > 0.05) (Supplemental Fig. 1). Asymmetric distribu-
tions were shown for the berry group investigating the effect 
on TAG, trim and fill method was further implemented to 
adjust for the publication bias (Supplemental Fig. 1).
Discussion
Principal findings
We are continually reminded of the health benefits of con-
suming more fruit and one consumer-friendly strategy to 
increase fruit consumption is through juice [12]. Even 
though the juicing process can influence the nutritional value 
of fruit; a systematic review has demonstrated that the intake 
of fruit and vegetable juice offered similar health benefits 
to the intake of whole fruit and vegetables [16]. The results 
from our review support the beneficial effects of juice and 
have revealed the potential of berries, in juiced form, to play 
a beneficial role in the diet to maintain cardiovascular health. 
High dose of 432 mL cranberry juice and small studies of 
cherry juice using up to 330 mL showed improvements to 
blood pressure in our meta-analysis, whereas the National 
Health Service adult portion size recommendation for fruit 
juice is no more than 150 mL per day [75], thus a downsized 
portion according to daily recommendation should be stud-
ied in intervention studies.
These findings suggest that interventions with berries, 
especially using juiced cranberries or cherries, as the most 
active substitutes for whole fruit, may effectively reduce 
SBP and DBP. However, the current analyses do not support 
the notion that the consumption of fruit powders or other 
fruit juices will confer a cardiovascular function-protective 
benefit.
Scientific analysis of findings
Our review showed that blueberry and grape in both juiced 
and freeze-dried forms have been frequently studied for 
their cardio and vascular protective effects, however, this 
quantitative analysis only supported an improvement on the 
outcomes by the consumption of cranberry juice and cherry 
juice.
A previous systematic review investigated the impact of 
fruit polyphenols on blood lipids (n = 17), platelet function 
(n = 9), BP (n = 9) and endothelium-dependent vasodilation 
(vascular function) (n = 7) and suggested that polyphenols 
from fruits such as pomegranate, purple grapes and ber-
ries are particularly effective at preventing hypertension 
compared to other CVD risk factors [7]. Berries in par-
ticular were shown to possess cardio-protective properties; 
the underlying mechanisms highlighted include inhibitory 
effects on inflammatory gene expression, oxidative stress, 
carbohydrate digestive enzymes and foam cell formation as 
well as increased effect on nitric oxide synthase following 
anthocyanins, the major polyphenol in berries [8].
A previous meta-analysis has grouped RCTs without sep-
arating the type of fruit, thus the magnitude of the effects of 
different fruit juice interventions were not compared. Their 
results supported the overall consumption of various fruit 
juices to significantly lower DBP by 2.07 mm Hg (95% CI 
− 3.75 to − 0.39; P = 0.02), whereas no improvement in 
SBP or lipid levels was obtained within 8 included RCTs 
[76]. In comparison with this previous report, the present 
report confirms the significant effects on DBP and reveals 
also significant effects on SBP.
In another meta-analysis of 95 prospective studies of 
fruit and vegetable intake, Aune et al. [2] found that fruit 
juice intake had little association with CVD and total 
cancer, while slight inverse associations were observed 
for CHD with RR (95% CI) 0.79 (0.63–0.98), stroke 
with RR (95% CI) 0.67 (0.60–0.76) and all-cause mor-
tality with RR (95% CI) 0.87 (0.83–0.91) every 100 g/
day increment, however, the very low number of studies 
(n = 2) makes these findings preliminary and more studies 
are needed before any firm conclusions can be drawn [2]. 
Furthermore, there is evidence showing that increasing 
the consumption of fruit juice by one serving per day was 
associated with a 7% greater incidence of type 2 diabetes 
(95% CI 0.8% to 14%) [77] and there is also greater risk of 
weight gain with higher consumption of fruit juice, prob-
ably because of the high sugar content and excess calo-
ries provided [78]. Fruit juice contains quantities of sugar 
classified as ‘free’ sugars like sucrose, compared with 
whole fruit in which the sugars are classified as intrin-
sic. Increased dietary fructose following sucrose intake 
is reported to increase de novo lipogenesis (DNL) levels 
and VLDL, which has been shown to increase the risk 
of developing non-alcoholic fatty liver disease (NAFLD) 
[79]. Therefore, cautious interpretations should be made 
when promoting fruit juice consumption as healthy options 
to increase fruit and vegetable intake.
Other epidemiological evidence has indicated an 
inverted association between fruit intake and CVD 
risk factors. Among 34,492 CVD-free postmenopausal 
women in the Iowa Women’s Health Study with 16 years 
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of follow-up, a significantly reduced risk ratio of CVD 
mortality was associated with intake of at least once per 
week of apples and pears, oranges, grapefruit, blueber-
ries, strawberries, grapes and raisins after adjustment for 
age and energy [4]. However, following adjustment for 
other confounding covariates, the significance was only 
retained for the intake of strawberries, apples and pears. 
In a further investigation of strawberry intake for its 
cross-sectional association with lipids and CRP profiles, 
only a borderline significance was reported for a reduced 
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Fig. 2  The effect of berry interventions including a cranberry juice, b grape juice and c grape powder assessing FMD and d blueberry powder, e 
grape juice and f pomegranate juice assessing PWV
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Fig. 3  The effect of berry interventions including a barberry juice, b blueberry powder, c cranberry juice, d freeze-dried strawberry, e grape 
juice, f grape powder, g pomegranate juice and h raspberry powder assessing SBP
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CRP levels [80]. Aune et al. [2] also reported an inverse 
association between high vs. low berry consumption and 
all-cause mortality in a meta-analysis, whereas no similar 
associations were observed for CHD and CVD [2].
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c. 240ml, 480ml, 460ml, 480ml, 500ml, 56 days, 28 days, 120 days, 56 days, 28 days
d. 490ml, 355ml, 240ml, 200ml, 56 days, 84 days, 14 days, 84 days
e. 46g, equivalent to 2 cups of grape, 30 days
f. 330ml, 240ml, 100ml, 28 days, 90 days, 56 days
g. 750mg, 84 days
Fig. 4  The effect of berry interventions including a barberry juice, b blueberry powder, c cranberry juice, d grape juice, e grape powder, f pome-
granate juice and g raspberry powder assessing DBP
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Our review has also shown elevated sVCAM-1 level 
after the berries intervention, however, some authors have 
suggested that the magnitude of the increase in sVCAM-1 
may not be clinically relevant, as the other vascular inflam-
matory markers did not change between the treatment and 
the control group after the interventions [41], which is also 
in line with the results of other inflammatory markers in 
our review. Aside from this, Bardagjy et al. [41] and Ruel 
et al. [44] reported significantly higher sVCAM-1 levels in 
the treatment group at the baseline compared to the con-
trol, which may have contributed to the elevated sVCAM 
level after the interventions in the berries-treated group. 
Although the consumption of a range of berries have been 
linked with improved cardiovascular health, considering 
the results from our review and previous evidence, cur-
rent evidence is insufficient and inconsistent to substanti-
ate the consumption of specific berries or other fruit as a 
cardiovascular-protective dietary strategy.
Implications for health and future research
Among our results, SBP improved significantly by over 
3 mmHg after interventions with specific berries and cherry 
juice, which may likely have practical implications as blood 
Study
Random effects model
Heterogeneity: I2 = 0%, 2 < 0.0001, p = 0.98
Test for overall effect: t1 = 41.21 (p = 0.02)
Lynn, et al., 2014 (UK)
Desai, T., et al. (2018) UK
Total
36
25
11
Mean
110.20
114.00
SD
12.5800
12.0000
Experimental
Total
32
21
11
Mean
113.36
117.00
SD
11.8800
12.0000
Control
15 10 5 0 5 10
Mean Difference MD
3.11
3.16
3.00
95% CI
[ 4.06; 2.15]
[ 10.24;  3.92]
[ 13.03;  7.03]
Weight
100.0%
66.7%
33.3%
Study
Random effects model
Heterogeneity: I2 = 0%, 2 = 0.0024, p = 0.89
Test for overall effect: t1 = 1.65 (p = 0.35)
Lynn, et al., 2014 (UK)
Desai, T., et al. (2018) UK
Total
36
25
11
Mean
69.20
72.00
SD
9.8600
10.0000
Experimental
Total
32
21
11
Mean
69.90
72.00
SD
7.6200
10.0000
Control
10 5 0 5 10
Mean Difference MD
0.51
0.70
0.00
95% CI
[ 4.45; 3.43]
[ 5.76; 4.36]
[ 8.36; 8.36]
Weight
100.0%
73.2%
26.8%
A. Forest plot of the effect of cherry juice interventions on SBP 
B. Forest plot of the effect of citrus juice interventions on SBP 
C. Forest plot of the effect of cherry juice interventions on DBP 
a. cherry juice
b.
c.
d. cherry juice
*Note
a. 250ml and 30 ml, 42 days and 20 days
b. 340ml, 180 days
c. both are 500ml and for 28 days
d. 250ml and 30 ml, 42 days and 20 days
Fig. 5  The effect of a cherry juice and b grapefruit juice, c orange juice interventions assessing SBP and d cherry juice interventions assessing 
DBP
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pressure is an important indicator not just for endothelial 
function, but also for CVD mortality risk [81]. A report from 
the Joint National Committee and several meta-analyses 
have estimated that lowering SBP by 5 mmHg or more could 
decrease stroke risk by 13% [82], CVD risk by 3% to 38% 
[83], deaths from stroke by 14%, deaths from heart diseases 
by 9% and overall mortality by 7% [84].
However, we only analysed two cherry juice studies with 
relatively small sample sizes in this review and no other 
risk factors were improved by this intervention. It would be 
helpful to have more studies on this topic in order to inform 
policymakers in nutrition. Future studies on supplementing 
berries (i.e. cranberries, blueberries, grapes) with a sufficient 
sample size are warranted, as these appear to have the big-
gest potential to improve endothelial function and cardiovas-
cular function. Further studies on this topic incorporating 
effect sizes with interpretation from CVD risk reduction are 
also required.
Strengths and limitations
To our knowledge, this is the first systematic review and 
meta-analysis to compare the impact of fruit in various 
delivery forms, on cardiovascular health. We also used the 
newly developed Hartung–Knapp–Sidik–Jonkman method 
for random-effects model in meta-analysis in addition to a 
comprehensive search of the literature in the topic. There 
are limitations to our review, however. As explored by the 
subgroup analysis, the significant moderate-to-substantial 
heterogeneity among the berry group majorly contributed 
to grape juice and pomegranate juice studies (Figs. 3, 4), 
however, the number of studies within grape juice and pome-
granate juice interventions (n ranged from 3 to 4) were too 
few to perform subgroup analysis. The high heterogeneity 
could be explained by the different populations and regions 
and participant characteristics at baseline within these few 
studies. Physical activity level has been considered as cofac-
tor, but no adjustments for physical activity level have been 
applied among the included studies in this review.
There is limited study data under some types of interven-
tions investigating all risk factors (i.e. grape powder and 
cherry juice) to be meta-analysed; and even though studies 
supplementing cranberry juice have shown an significant 
effect, they are not accompanied by improvements to other 
risk factors and are limited to relatively small sample sizes 
within 2 studies, so the implications of our results should 
be treated with caution. Heterogeneities presented in our 
results, however, were explored by subgroup analyses of dif-
ferent intervention subgroups, due to the limited number of 
studies under each participants characteristic and country 
region, we were unable to further compare among differ-
ent baseline-characterised subjects (i.e. physical activity, 
gender), regions (i.e. western and other countries) and juice 
qualities.
Conclusion
This review has highlighted a scarcity of intervention studies 
aimed at improving endothelial function and cardiovascular 
health by consuming berries, citrus and cherries in different 
forms such as freeze-dried and powdered fruit or as fruit 
juice. The quantitative analysis led us to further explore the 
potential of various berries, cherries and citrus-based inter-
ventions to improve endothelial function and cardiovascular 
health. There is a potential for berries in juiced forms to 
benefit cardio-health, however, these are only suggestive 
and raised from non-substantial evidence from a few stud-
ies within each intervention type. Inconsistent evidence was 
reported considering results from our analysis along with 
other reviews regarding the effect of fruit juice on CVD risk 
factors. More research supplementing summarised interven-
tions in this review is warranted to reinforce the evidence 
and to further substantiate the health benefits of specific 
fruit-based interventions.
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